Stephen P. Fortmann, MD

Biography

Stephen Fortmann, MD, is an internist and epidemiologist who conducts research on heart disease prevention. He has conducted both population- and individual-level studies of cardiovascular risk factors and disease rates, smoking cessation, the influence of tobacco marketing on adolescent smoking, and exercise and diet change. Dr. Fortmann has more than 35 years of experience leading community and clinical research, beginning with the Stanford Five-City Project, a community cardiovascular disease prevention study funded by NHLBI from 1978 to 1998. He has published over 220 peer-reviewed journal articles.

Dr. Fortmann is currently leading a study to see if increased access to public transit benefits health or reduces health care costs. He is also jointly leading a study of cardiovascular disease among Asians and Pacific Islanders in Hawaii and California, and is a co-investigator on a study of diabetes disparities among these groups in Hawaii. Dr. Fortmann also serves as site PI on GRADE, a comparative effectiveness study seeking the best second-line drugs for diabetes.  With Dr. Stephanie Fitzpatrick he is also studying the implementation of the diabetes prevention program in KPNW.

Dr. Fortmann came to CHR from Stanford University Medical School, where he was director of the Stanford Prevention Research Center and the Stanford Preventive Cardiology Clinic. He is the C. F. Rehnborg Professor in Disease Prevention (Emeritus) at Stanford and in 2005 he was elected to the National Academy of Medicine. Dr. Fortmann received his MD from the University of California, San Francisco, and postdoctoral training at Stanford University.

Selected Publications

 
  • Farquhar JW, Fortmann SP, Flora JA, Taylor CB, et al. Effects of community-wide education on cardiovascular disease risk factors. The Stanford Five-City Project JAMA 1990;264:359-365.
  • Fortmann SP, Varady AN. Effects of a community-wide health education program on cardiovascular disease morbidity and mortality: The Stanford Five-City Project. Am J Epidemiol 2000; 152: 316–323.
  • Henriksen L, Schleicher NC, Feighery EC, Fortmann SP. A longitudinal study of exposure to retail cigarette advertising and smoking initiation. Pediatrics 2010 Aug; 126(2):232-8 PMID 20643725; PMC3046636.
  • Henriksen L, Schleicher NC, Dauphineé A, Fortmann SP. Targeted advertising, promotion, and price for menthol cigarettes in California high school neighborhoods. Nicotine Tobacco Res 2012; 14:116-21 (Epub ahead of print, 24 June 2011: doi 10.1093/ntr/ntr122). [PMID 21705460; PMC 3592564]
  • Killen JD, Fortmann SP, Schatzberg AF, Arredondo C, et al. Extended cognitive behavior therapy for cigarette smoking cessation. Addiction 2008; 103: 1381–1390.
  • Fortmann SP, Burda BU, Senger CA, Lin JS, Whitlock EP. Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: An updated systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2013; 159(12):824-834. [PMID 24217421; PMC3636284].
  • Wang EJ, Wong EC, Dixit AA, Fortmann SP, Linde RB, Palaniappan LP. Type 2 diabetes: Identifying high risk Asian American subgroups in a clinical population. Diabetes Research and Clinical Practice 2011; 93:248-254 [epub June 10; doi: 10.1016/j.diabres.2011.05.025] [PMID 21665315; PMC 3156287]
  • Gurwitz JH, Go AS, Fortmann SP: Statins for primary prevention in older adults:  Uncertainty and the need for more evidence. JAMA Viewpoint 2016; 316 (19): 1971-2.  PMID: 27838724; PMC5429025
  • Bailey SR, Heintzman J, Marino M, Jacob L, Puro J, DeVoe JE, Burdick T, Hazlehurst B, Cohen DJ, Fortmann SP. Smoking cessation assistance: Before and after Stage 1 Meaningful Use implementation. Am J Prev Med 2017; 53(2): 192–200 [published online 29-MAR-2017; doi 10.1016/j.amepre.2017.02.006] PMID: 28365090; PMC5522621
  • Bailey S, Stevens VJ, Fortmann SP, Kurtz SE, McBurnie MA, Priest E, Puro J, Solberg LI, Schweitzer R, Masica AL, Hazlehurst B. Long term outcomes from repeated smoking cessation assistance in routine primary care. Am J Health Promotion [published online March 2018; DOI: 10.1177/0890117118761886] PMID: 29534598

Story

Medicare Invests in Diabetes Prevention, and Health Researchers Seize the Moment

A new four-year study will evaluate diabetes prevention programs at Kaiser Permanente Northwest.

Sep 20, 2017

Story

National Diabetes Trial Gets Big Boost from KP Center for Health Research

On the NIDDK’s Glycemia Reduction Approaches in Diabetes study, CHR shines as a top-performing recruitment site

July 13, 2016